Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.49 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.49 |
| ▸ | ALB | P02768 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.49 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.49 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | POLG | P54098 | 2/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.42 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5666376 | 0.92 | POLB (0.53) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL28799641 | 0.92 | POLB (0.53) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL7794947 | 0.90 | POLB (0.51) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL51649 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL127179 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL3178721 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL13471863 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL4199985 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL4201132 | 0.89 | POLB (0.50) | POLBLMNAPDE3ACACNA1FALB | |
| SCHEMBL3896397 | 0.87 | POLB (0.48) | POLBLMNAPDE3ACACNA1FALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115315430-A | Nucleic acid synthesis method using segmented phosphoramidite compound | 日东电工株式会社 | 2022-11-08 | — | — | CN | disclosed |
| US-7767449-B1 | Methods using modified vaccinia virus | HEALTH RESEARCH INCORPORATED (US) | 2010-08-03 | — | — | US | disclosed |
| EP-1435826-A4 | DIAGNOSTIC OR THERAPEUTIC SOMATOSTATIN OR BOMBESIN ANALOG CONJUGATES AND USES THEREOF | UNIV TULANE (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008085611-A2 | DESIGNER THERAPHY OF PANCREATIC TUMORS | UNIVERSITY OF MIAMI (US) | 2008-07-17 | — | — | WO | disclosed |
| US-20060160125-A1 | Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms | UNIVERSITY OF ROCHESTER (US) | 2006-07-20 | — | — | US | disclosed |
| US-7033753-B1 | Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms | UNIVERSITY OF ROCHESTER (US) | 2006-04-25 | — | — | US | disclosed |
| EP-1435826-A2 | DIAGNOSTIC OR THERAPEUTIC SOMATOSTATIN OR BOMBESIN ANALOG CONJUGATES AND USES THEREOF | The Administrators of The Tulane Educational Fund (US) | 2004-07-14 | — | — | EP | disclosed |
| US-6677311-B1 | DNA EXPRESSING AN EXOGENOUS HERPES SIMPLEX THYMIDINE KINASE ENZYME SELECTIVELY CONVERTS LATENT TOXIN INTO CELL TOXIN TO INHIBIT GROWTH OR CAUSE DEATH OF A TISSUE-TYPE OR CELL LINE | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2004-01-13 | — | — | US | disclosed |
| WO-2003028527-A2 | DIAGNOSTIC OR THERAPEUTIC SOMATOSTATIN OR BOMBESIN ANALOG CONJUGATES AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2003-04-10 | — | — | WO | disclosed |
| EP-0149040-B2 | Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same | NOVAGENE INC (US) | 2002-05-22 | — | — | EP | disclosed |
| US-4609548-A | NON-PRODUCERS OF THYMIDINE KINASE; VETERINARY MEDICINE | NOVAGENE, LTD. (US) | 1986-09-02 | — | — | US | disclosed |
| US-4603112-A | Modified vaccinia virus | HEALTH RESEARCH, INCORPORATED (US) | 1986-07-29 | — | — | US | disclosed |
| US-4579821-A | FUSION OF DNA PROMOTHER/REGULATOR WITH GENES | UNIVERSITY PATENTS, INC. (US) | 1986-04-01 | — | — | US | disclosed |
| EP-0094428-A4 | CONTROL OF DNA SEQUENCE TRANSCRIPTION. | UNIVERSITY PATENTS INC (US) | 1986-01-07 | — | — | EP | disclosed |
| EP-0149040-A2 | Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same | NOVAGENE, INC. (US) | 1985-07-24 | — | — | EP | disclosed |
| US-4514497-A | DO NOT PRODUCE THYMIDINE KINASE- TEMPERATURE RESISTANCE | NOVAGENE, LTD. (US) | 1985-04-30 | — | — | US | disclosed |
| US-4465769-A | Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-08-14 | — | — | US | disclosed |
| EP-0094428-A1 | CONTROL OF DNA SEQUENCE TRANSCRIPTION. | UNIVERSITY PATENTS INC (US) | 1983-11-23 | — | — | EP | disclosed |
| EP-0083286-A2 | Modified vaccinia virus and methods for making and using the same | HEALTH RESEARCH, INCORPORATED (US) | 1983-07-06 | — | — | EP | disclosed |
| WO-1983001783-A1 | CONTROL OF DNA SEQUENCE TRANSCRIPTION | UNIVERSITY PATENTS INC (US) | 1983-05-26 | — | — | WO | disclosed |